Island Pharmaceuticals joins Fraser Palamara on Stockhead TV to talk about its Phase 2b trial of ISLA-101 in dengue fever. ... Read More The post Long Shortz with Island Pharmaceuticals: Phase 2b ...
of global funding was focused on drug development, a 106% increase from even 2008, and a step in the right direction considering this amount is three times the total amount what the NIH dengue ...
Degrees Pharmaceuticals, Inc. (NASDAQ: SXTP; SXTPW) shared in a press release that it has successfully enrolled the first patient in the NCT06478641 expanded access clinical study. This study focuses ...